Women in their 40s have lower mammographic tumor detectability

Jul 27, 2010

The reduced effectiveness of mammographic screening in women in their forties is primarily due to lower detectability instead of faster tumor growth rate, according to a study published online July 27 in The Journal of the National Cancer Institute.

Mammography screening outcomes, measured in terms of tumor size, lifetime gained and mortality, have typically been poorer in women in their forties than women in their fifties, partly because tumors of younger women tend to grow more quickly, so by the time they grow to a detectable size, they would have likely already been detected by a routine examination. Younger women also tend to have denser breast tissue, which can mask tumors, reducing their detectability on .

To investigate which factor—faster tumor growth rates, or reduced mammographic detectability—contributes to poorer mammography screening outcomes in younger women, Sylvia K. Plevritis of the Department of Radiology at the Stanford University School of Medicine, and colleagues, used a computer simulated model to estimate the relative effect of biology and technology on mammograms of women in their forties, compared to women in their fifties and sixties.

The researchers used the Breast Cancer Screening Simulator to create hypothetical screening scenarios whereby they could estimate the median tumor size detectable on a mammogram and the mean tumor growth rate in women aged 40-49 and 50-69.

The researchers concluded from their simulation model that lowered mammographic tumor detectability accounted for 79% and faster tumor volume doubling time accounted for 21% of the poorer sensitivity in mammography screening among younger women, compared with older women.

The authors write, "The age-specific differences in mammographic tumor detection contribute more than age-specific differences in rates to the lowered performance of mammography screening in younger women."

One limitation of the analysis, according to the authors, is that it did not take into account that low mammographic tumor detectability could be considered a breast cancer risk factor. They write: "More research is needed to not only establish a better relationship between mammographic breast density and risk but also understand the differences in tumor characteristics in dense vs non-dense breast tissue."

Explore further: Older prostate cancer patients should think twice before undergoing treatment

More information: jnci.oxfordjournals.org/

add to favorites email to friend print save as pdf

Related Stories

Breast cancer tumors grow faster in younger women

May 08, 2008

A new approach to estimating tumour growth based on breast screening results from almost 400,000 women is published today BioMed Central’s open access journal, Breast Cancer Research. This new model can also estimate the pr ...

Recommended for you

CT radiation risk less than risk of examination indicator

12 hours ago

(HealthDay)—For young adults needing either a chest or abdominopelvic computed tomography (CT), the short-term risk of death from underlying morbidity is greater than the long-term risk of radiation-induced ...

User comments : 0

More news stories

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Do salamanders hold the solution to regeneration?

Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...

Lab sets a new record for creating heralded photons

(Phys.org) —Entanglement, by general consensus of physicists, is the weirdest part of quantum science. To say that two particles, A and B, are entangled means that they are actually two parts of an inseparable ...

Protein study suggests drug side effects are inevitable

A new study of both computer-created and natural proteins suggests that the number of unique pockets – sites where small molecule pharmaceutical compounds can bind to proteins – is surprisingly small, meaning drug side ...